EMBOLIZATION PARTICLE MARKET ANALYSIS

Embolization Particle Market, by Product type (Radioembolization Spheres, Microspheres, Drug Eluting Beads, PVA Particles & Gelfoam Particles, and Other Particles), by Application (Peripheral Vascular Disease, Neurology, Oncology, Urology, and Others), by End User (Hospitals & Clinics, Ambulatory Centers, and Others) and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) — Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI2374
Formats :
Excel and PDF
Industry : Medical Devices

Market News

Key players are focusing on mergers & acquisitions and new product launches in order to retain dominant position in the market. For instance, in November 2018, Boston Scientific announced it plans to acquire BTG plc is a global healthcare company focused on interventional medicine. This will help the company to develop and commercialize products used in minimally-invasive procedures targeting cancer and vascular diseases